CCL18 and breast cancer: Additionally, quantification of human hypoxanthine phosphor-ribosyl transferase (HPRT) mRNA also demonstrated that CCL18 increased the number of metastatic breast cancer cells in the lungs and livers of the xenografted mice by 3-fold (Figure 6D).